ETANA ESTABLISHES STRATEGIC COOPERATION WITH BEIGENE FOR IMMUNOTHERAPY CANCER DRUG (TISLELIZUMAB)

Jakarta, 29 January 2024 – PT Etana Biotechnologies Indonesia (Etana) a local Indonesian biopharmaceutical company has entered a strategic collaboration with BeiGene, a global, science-driven biotechnology company. Nathan Tirtana, President Director of Etana together with Adam Roach BeiGene’s Vice President, and Head of Asia-Pacific, has committed to cooperate for the commercialization, development, and technology transfer of the Tislelizumab product.

Read More
Lusy Andriani
ETANA'S MRNA VACCINE PRODUCTION FACILITY RECEIVES BPOM'S VISIT

Jakarta, 25 October 2023 – PT Etana Biotechnologies Indonesia (Etana), an indigenous Indonesian biopharmaceutical company, today received a visit from the Head of the Food and Drug Supervisory Agency (BPOM) to review the readiness of the production facility for raw materials for mRNA vaccines and multi-product filling facilities.  Concurrently during the visit, they also handed over the approval for distribution permits and approval for the implementation of clinical trials for the PCV13 vaccine product that will be produced by Etana.

Read More
Lusy Andriani
ETANA STRENGTHENS BIOPHARMACEUTICAL COOPERATION WITH CANSINOBIO

Jakarta, 18 October 2023 – PT Etana Biotechnologies Indonesia (Etana), a biopharmaceutical company from Indonesia, has entered into a strategic collaboration with CanSino Biologics Inc (CanSinoBIO) at the Indonesia-People's Republic of China (PRC) Business Forum that was held at China World Hotel, Beijing, PRC, on Monday, October 16, 2023. This forum was held to commemorate the 10th anniversary of the Belt and Road Initiative (BRI), as well as to encourage joint development between the two countries.

Read More
Lusy Andriani
ETANA STRENGTHENS COOPERATION WITH BRIN AND UNSW, SUPPORTING RESEARCH AND INNOVATION IN HEALTH FIELDS

Jakarta, 22 September 2023 – PT Etana Biotechnologies Indonesia (Etana), an indigenous Indonesian biopharmaceutical company which is the first company in ASEAN to have an mRNA technology platform, collaborates with the National Research and Innovation Agency (BRIN) and the University of New South Wales (UNSW) Australia in the development of research and innovation in the health sector, particularly in mRNA technology.

Read More
Lusy Andriani
ETANA WITH KPCDI HOLDS EDUCATIONAL EVENT ON KIDNEY TRANSPLANTATION AND ANEMIA IN CHRONIC KIDNEY PATIENTS

Jakarta, 17 September 2023 – PT Etana Biotechnologies Indonesia (Etana) together with the Indonesian Dialysis Patient Community (KPCDI) held kidney health education with resource person Dr. Dr. Maruhum Bonar H. Marbun, Sp.PD-KGH., FINASIM and dr. Mirna Nurasri Praptini, SpPD-KGH., M.Epid., FINASIM. The topics raised in this education were what to pay attention to during a kidney transplant and how to prevent and treat anemia in chronic kidney patients, which was attended by 150 kidney failure patients from Jakarta and surrounding areas.

Read More
Lusy Andriani
ETANA WITH DKI JAKARTA HEALTH OFFICE HELD HEALTH EDUCATION ON HEPATITIS AND TUBERCOLOSIS

Jakarta, 3 September 2023 – PT Etana Biotechnologies Indonesia (Etana) in collaboration with the DKI Jakarta Health Service (Dinkes) is holding Health education and Cognition of Infectious Disease Management with the theme "Test and Treat Immediately". The health education is a part of the World Hepatitis Day Commemoration of the DKI Jakarta Province that is specifically discusses Hepatitis and Tubercolosis.  The speaker for Hepatitis education is Dr. Imelda Maria Loho, Sp. PD., FINASIM who will explain Hepatitis and its Prevention with Vaccination.

Read More
Lusy Andriani